Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Prostate Cancer Metastatic × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 93 Lung Neoplasms 38 Breast Neoplasms 27 Triple Negative Breast Neoplasms 25 Ovarian Neoplasms 22 Endometrial Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 16 Small Cell Lung Carcinoma 16 Neoplasms 14 Fallopian Tube Neoplasms 13 Head and Neck Neoplasms 12 Uterine Cervical Neoplasms 10 Neoplasm Metastasis 10 Colorectal Neoplasms 10 Carcinoma, Transitional Cell 9 Carcinoma, Squamous Cell 9 Prostatic Neoplasms 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Esophageal Squamous Cell Carcinoma 8 Esophageal Neoplasms 8 Recurrence 7 Oropharyngeal Neoplasms 6 Urinary Bladder Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Adenocarcinoma of Lung 5 Pancreatic Neoplasms 4 Neuroblastoma 4 Mesothelioma 4 Lymphoma, Large B-Cell, Diffuse 4 Lung Diseases 4

Interventions

Androgen Antagonists 3 Radiosurgery 2 pembrolizumab 1 fludrocortisone acetate 1 enzalutamide 1 darolutamide 1 cabazitaxel 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisone 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Hydrocortisone 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Dexamethasone 1 Carboplatin 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05563558 2024-06-11

PEAPOD_FOS

Fundacion Oncosur

Phase 2 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡